START - Midwest — Grand Rapids, Michigan

START - Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

START - Midwest has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular.

Sponsors: Asana BioSciences, MacroGenics, Whitehawk Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START - Midwest?

START - Midwest has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START - Midwest conducted?

START - Midwest has 5 clinical trials on record, with 4 currently active. Their work covers Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular.

Is START - Midwest accredited by Crixeo Health?

Yes — START - Midwest holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about START - Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.